Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Podolec

Showing results (261-270 of 278) with videos related to

Pageof 28
Sort By:
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|March 27, 2023
Acute myocardial infarction reparation/regeneration strategy using Wharton's jelly multipotent stem cells as an 'unlimited' therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trialEwa Kwiecien, Leszek Drabik, Adam Mazurek, et al.
Kardiologia Polska|September 28, 2023
Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: A position statement of the Polish Cardiac SocietyJacek Grzybowski, Piotr Podolec, Katarzyna Holcman, et al.
Przeglad Lekarski|April 29, 2003
Coronary microcirculation and reperfusion failure. Do we know what diagnostic tools we have?Cafer Zorkun, Krzystztof Zmudka, Dariusz Dudek, et al.
Orphanet Journal of Rare Diseases|January 18, 2024
A review and recommendations for oral chaperone therapy in adult patients with Fabry diseaseMichał Nowicki, Stanisława Bazan-Socha, Beata Błażejewska-Hyżorek, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|October 11, 2018
Temporal changes in the pattern of invasive angiography use and its outcome in suspected coronary artery disease: implications for patient management and healthcare resources utilizationJakub Chmiel, Miłosz K Książek, Weronika Stryszak, et al.
Cells|June 2, 2021
Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated CardiomyopathyPaweł Rubiś, Ewa Dziewięcka, Magdalena Szymańska, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2006
Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patientsAndrzej Kraśniak, Maciej Drozdz, Mieczysław Pasowicz, et al.
Heart and Vessels|December 23, 2016
Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRRPaweł Rubiś, Sylwia Wiśniowska-Śmiałek, Barbara Biernacka-Fijałkowska, et al.
Archives of Medical Science : AMS|August 30, 2018
Practice setting and secondary prevention of coronary artery diseasePiotr Jankowski, Danuta Czarnecka, Leszek Badacz, et al.
Kardiologia Polska|September 20, 2011
Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulationMichał Owsiak, Agnieszka Pelc-Nowicka, Leszek Badacz, et al.
Pageof 28

Showing results (261-270 of 278) with videos related to

Sort By:
Pageof 28
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|March 27, 2023
Acute myocardial infarction reparation/regeneration strategy using Wharton's jelly multipotent stem cells as an 'unlimited' therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trialEwa Kwiecien, Leszek Drabik, Adam Mazurek, et al.
Kardiologia Polska|September 28, 2023
Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: A position statement of the Polish Cardiac SocietyJacek Grzybowski, Piotr Podolec, Katarzyna Holcman, et al.
Przeglad Lekarski|April 29, 2003
Coronary microcirculation and reperfusion failure. Do we know what diagnostic tools we have?Cafer Zorkun, Krzystztof Zmudka, Dariusz Dudek, et al.
Orphanet Journal of Rare Diseases|January 18, 2024
A review and recommendations for oral chaperone therapy in adult patients with Fabry diseaseMichał Nowicki, Stanisława Bazan-Socha, Beata Błażejewska-Hyżorek, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|October 11, 2018
Temporal changes in the pattern of invasive angiography use and its outcome in suspected coronary artery disease: implications for patient management and healthcare resources utilizationJakub Chmiel, Miłosz K Książek, Weronika Stryszak, et al.
Cells|June 2, 2021
Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated CardiomyopathyPaweł Rubiś, Ewa Dziewięcka, Magdalena Szymańska, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2006
Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patientsAndrzej Kraśniak, Maciej Drozdz, Mieczysław Pasowicz, et al.
Heart and Vessels|December 23, 2016
Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRRPaweł Rubiś, Sylwia Wiśniowska-Śmiałek, Barbara Biernacka-Fijałkowska, et al.
Archives of Medical Science : AMS|August 30, 2018
Practice setting and secondary prevention of coronary artery diseasePiotr Jankowski, Danuta Czarnecka, Leszek Badacz, et al.
Kardiologia Polska|September 20, 2011
Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulationMichał Owsiak, Agnieszka Pelc-Nowicka, Leszek Badacz, et al.
Pageof 28